Abstract
The complexity and the variety of problems to be managed in the climacteric period strongly suggests that one doctor act as a primary “point of reference” for the patient offering advice based on her individual history, family, and lifestyle [1–3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians Ann Intern Med 1992;117(12):1038–41.
Genazzani AR, Zichella L (editors). La terapia ormonale in climaterio o postmenopausa. Atti della 1 conferenza Nazionale di consenso in scienze ginecologoche e ostetriche, Madonna do Campiglio 17–24 marzo 1996-Churchill Livingstone.
“Women’s health” supplement to The Lancet. Lancet 1997;349(Suppl.):1–26.
Traynor V, Britt H, Sayer GP. Menopause: Its management in general practice. Aus Family Physician 1995;24:407–11.
O’Connor V, et al. The menopause and hormone replacement therapy: Australian general practitioners’ self-reported opinions, attitudes and behaviour. Fam Pract 1996;13:421–26.
Hammond CB. Management of menopause. Am Fam Phys 1997;55:1667–73.
Beresford SA, et al. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in postmenopausal women. Lancet 1997;349:458–61.
Colditz GA, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 1995;332:1589–93.
Wise J. Hormone replacement therapy increases risk of breast cancer. BMJ 1997;315:969.
Sellers TA, et al. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med 1997;127:973–80.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis. Lancet 1997;350:1047–43. See also commentaries pages 1042, 1043.
Nicol-Smith L. Causality, menopause, and depression: A critical review of the literature. BMJ 1996;313:1229–32.
Hunter MS. Depression and the menopause. BMJ 1996;313:1217–18.
AHA Science Advisory. Guide to primary prevention of cardiovascular diseases. Circulation 1997;95:2329–31.
The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestogen regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestogen Interventions (PEPI) Trial. JAMA 1995;273:199–208.
Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. New Engl J Med 1993;329:247–53.
Grodstein F, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Engl J Med 1996;335:453–61.
Rossouw JE. Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon. Circulation 1996;94:2982–85.
Wenger NK. Coronary heart disease: An older woman’s major health risk. BMJ 1997;315:1085–90.
Pedersen AT, et al. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:1277–83.
Consensus development statement: Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 1997;7:1–6.
Schneider DL, et al. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. JAMA 1997;277:543–47 (JAMA ed. italiana vol. 9 n.6:264–70).
Borroni M, et al. Idee guida per la prevenzione e la diagnosi di osteporosi e per la prevenzione delle fratture su base osteoporotica. Ricercae Practica 1997;13:158–67.
Grodstein F, Stampfer MJ, et al. Postmenopausal hormone therapy and mortality. New Engl J Med 1997;336:1769–75.
Grady D, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016–37.
Ettinger B, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6–12.
Crosignani PG, Paoletti R (editors). Hormone replacement and the menopause. Eur Men J 1996;3(3):195–256.
Guilbert JJ. Guida pedagogica. Armando editore 1981.
Author information
Consortia
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers and Fondazione Giovanni Lorenzini
About this chapter
Cite this chapter
Tresoldi, G., Italian Society of General Practitioners. (1999). Menopause: What Is the Role of the General Practitioner?. In: Women’s Health and Menopause. Medical Science Symposia Series, vol 13. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-37973-9_41
Download citation
DOI: https://doi.org/10.1007/978-0-585-37973-9_41
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5906-7
Online ISBN: 978-0-585-37973-9
eBook Packages: Springer Book Archive